Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Dexamethasone Sodium Phosphate prices in Germany, the highest-cost reporting region, rose 7.9% in H1 2026, climbing from USD 45.5/KG in Q1 to USD 49.1/KG by Q2 as spring anti-inflammatory, immunosuppressive, and emergency medicine formulation procurement and firmer corticosteroid synthesis intermediate costs drove consistent buying following the brief Q1 2026 pricing moderation. Globally, the average rose from USD 32.00/KG in Q1 to USD 34.56/KG in Q2, an 8.0% gain. For H2 2026, a global average of USD 34.80-38.50/KG is expected, with continued firming on Middle East supply disruptions and growing anti-inflammatory, immunosuppressive, and emergency medicine sector demand globally.
Dexamethasone Sodium Phosphate is the water-soluble disodium phosphate ester of dexamethasone, a synthetic 9-alpha-fluorinated 16-alpha-methylated glucocorticoid, produced by selective phosphorylation of the 21-hydroxyl group of dexamethasone using phosphorylation reagents under controlled conditions and conversion to the stable disodium salt, enabling high aqueous solubility for intravenous, intramuscular, and topical ophthalmic parenteral formulation. The compound binds the cytoplasmic glucocorticoid receptor, inducing nuclear translocation and modulating gene transcription to suppress inflammatory cytokine expression, reduce vascular permeability, and inhibit arachidonic acid cascade activation, with approximately twenty-five-fold greater anti-inflammatory potency than endogenous cortisol. The largest pull comes from hospital intravenous and intramuscular anti-inflammatory and immunosuppressive use across acute allergic reactions, anaphylaxis adjunct therapy, cerebral oedema management, and severe respiratory illness where guideline-recommended glucocorticoid immunomodulation is applied. Ophthalmic formulations for anterior uveitis and post-surgical ocular inflammation, chemotherapy anti-emetic adjunct, and adrenal insufficiency replacement therapy add further consistent demand. Corticosteroid synthesis intermediate costs, hospital formulary and emergency medicine procurement cycles, and regional API production capacity all feed into the price.
The balance of supply and demand for Dexamethasone Sodium Phosphate through H2 2026 leans moderately firm. Corticosteroid synthesis intermediate costs firmed from Middle East supply disruptions. Hospital formulary procurement, emergency medicine stockpile replenishment, and ophthalmic formulation demand are growing with expanding critical care and formulary access globally.
The main upside risk is synthesis intermediate cost increases alongside accelerating hospital formulary and emergency medicine programme procurement. The main downside risk is Chinese and Indian API surplus and generic competition maintaining competitive price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 34.80 - 38.50 | Synthesis cost firming and anti-inflammatory/emergency demand |
| United States | 37.30 - 41.00 | Steady hospital formulary and emergency medicine demand holds firm |
| China | 26.30 - 30.00 | Large API capacity keeps it the most affordable |
| Germany | 49.60 - 53.30 | High synthesis and energy costs keep it the most expensive |
| India | 36.30 - 40.00 | Growing hospital and export demand holds a firm middle |
US Dexamethasone Sodium Phosphate prices averaged USD 40.0/KG in Q2 2026, up 8.1% from USD 37.0/KG in Q1 2026. Firmer synthesis intermediate costs and spring anti-inflammatory and emergency medicine procurement drove consistent buying following the Q1 moderation.
Why did the price of Dexamethasone Sodium Phosphate change in Q2 2026 in the United States?
Firmer corticosteroid synthesis intermediate costs raised the API production floor. Hospital formulary anti-inflammatory, anaphylaxis adjunct, and cerebral oedema treatment procurement lifted buying. Chemotherapy anti-emetic and ophthalmic formulation demand provided additional support near USD 40.0/KG.
Chinese Dexamethasone Sodium Phosphate prices averaged USD 27.8/KG in Q2 2026, up 8.2% from USD 25.7/KG in Q1 2026, the lowest among the tracked markets. Spring hospital formulary and emergency medicine export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.
Why did the price of Dexamethasone Sodium Phosphate change in Q2 2026 in China?
Spring hospital formulary and emergency medicine export and domestic procurement lifted buying. Firmer domestic corticosteroid synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Dexamethasone Sodium Phosphate prices averaged USD 49.1/KG in Q2 2026, up 7.9% from USD 45.5/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Consistent hospital anti-inflammatory, emergency medicine, and ophthalmic demand maintained buying.
Why did the price of Dexamethasone Sodium Phosphate change in Q2 2026 in Germany?
Higher corticosteroid synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to steroid synthesis substrate chains. Consistent hospital formulary, emergency medicine, and ophthalmic formulation procurement maintained buying near USD 49.1/KG.
Indian Dexamethasone Sodium Phosphate prices averaged USD 38.1/KG in Q2 2026, up 7.9% from USD 35.3/KG in Q1 2026. Growing hospital formulary export and domestic emergency medicine demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Dexamethasone Sodium Phosphate change in Q2 2026 in India?
Growing hospital formulary and emergency medicine export and domestic procurement lifted buying. Firmer corticosteroid synthesis import costs raised the production floor. Ophthalmic formulation and chemotherapy anti-emetic export demand provided additional support near USD 38.1/KG.
US prices averaged USD 37.0/KG in Q1 2026, easing about 1.1% from Q4 2025. Post-quarter hospital formulary and emergency medicine procurement moderation and soft synthesis costs eased the market near USD 37.0/KG.
Why did the price of Dexamethasone Sodium Phosphate change in Q1 2026 in the United States?
Post-quarter hospital formulary and emergency medicine procurement moderation reduced buying urgency. Soft synthesis intermediate costs eased the production floor. The market eased to USD 37.0/KG before the Q2 spring procurement surge.
Chinese prices averaged USD 25.7/KG in Q1 2026, easing about 1.2% from Q4 2025. Post-Lunar New Year procurement moderation and soft synthesis costs held the market near USD 25.7/KG.
Why did the price of Dexamethasone Sodium Phosphate change in Q1 2026 in China?
Post-Lunar New Year hospital and emergency medicine procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 25.7/KG before the Q2 procurement surge.
German prices averaged USD 45.5/KG in Q1 2026, easing about 1.1% from Q4 2025. Post-quarter hospital formulary and emergency medicine procurement moderation and soft synthesis costs eased the European market near USD 45.5/KG.
Why did the price of Dexamethasone Sodium Phosphate change in Q1 2026 in Germany?
Post-quarter hospital and emergency medicine procurement moderation reduced urgency. Soft synthesis intermediate and energy costs eased the production floor. The market eased to USD 45.5/KG before the Q2 spring procurement surge.
Indian prices averaged USD 35.3/KG in Q1 2026, easing about 1.1% from Q4 2025. Post-holiday procurement moderation and soft synthesis import costs held the market near USD 35.3/KG.
Why did the price of Dexamethasone Sodium Phosphate change in Q1 2026 in India?
Post-holiday hospital and emergency medicine procurement moderation reduced urgency. Soft synthesis import costs eased the production floor. The market eased to USD 35.3/KG before the Q2 spring surge.
Global Dexamethasone Sodium Phosphate prices followed an alternating pattern, dipping in Q3 2025 and Q1 2026 on seasonal procurement moderation before recovering in Q4 2025 and surging in Q2 2026. The average eased from USD 32.0/KG in Q2 2025 to USD 31.68/KG in Q3, recovered to USD 32.32/KG in Q4, eased to USD 32.00/KG in Q1 2026, then surged to USD 34.56/KG in Q2 2026, a net gain of about 8.0% over the window. Corticosteroid synthesis intermediate cost cycles and hospital formulary and emergency medicine procurement seasonality drove the alternating pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 34.56 | +8.0% | ↑ Rising |
| Q1 2026 | 32.00 | -1.0% | ↓ Falling |
| Q4 2025 | 32.32 | +2.0% | ↑ Rising |
| Q3 2025 | 31.68 | -1.0% | ↓ Falling |
| Q2 2025 | 32.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Dexamethasone Sodium Phosphate prices firmed modestly through 2025 on consistent hospital formulary and emergency medicine demand. The global average opened near USD 31.8/KG in Q1 2025 and closed at USD 32.32/KG in Q4, a full-year gain of about 1.6%. Corticosteroid synthesis intermediate cost dynamics and hospital procurement seasonality drove the quarterly oscillation throughout the year.
US prices firmed from about USD 36.8/KG in Q1 2025 to USD 37.4/KG by Q4, a gain of 1.6%. Consistent hospital anti-inflammatory, emergency medicine, and ophthalmic demand maintained the modest upward trend.
Chinese prices firmed from roughly USD 25.5/KG in Q1 2025 to USD 26.0/KG by Q4, a gain of 2.0%. Growing hospital formulary export and domestic demand drove modest firming through the year.
German prices firmed from about USD 45.2/KG in Q1 2025 to USD 46.0/KG by Q4, a gain of 1.8%. Consistent hospital, emergency medicine, and ophthalmic demand and firm synthesis costs supported.
Indian prices firmed from roughly USD 35.0/KG in Q1 2025 to USD 35.7/KG by Q4, a gain of 2.0%. Growing hospital formulary export and domestic emergency medicine demand drove modest firming.
Expert Market Research: Your Source for Real-Time Dexamethasone Sodium Phosphate Price Intelligence
Expert Market Research tracks Dexamethasone Sodium Phosphate prices continuously across every major producing and consuming region. The team traces causation through corticosteroid synthesis intermediate economics, hospital formulary and emergency medicine procurement cycles, and regional API production capacity. Contact Expert Market Research today for Dexamethasone Sodium Phosphate pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Hospital intravenous and intramuscular anti-inflammatory and immunosuppressive formulation across acute allergic reactions, anaphylaxis adjunct, cerebral oedema, and severe respiratory illness treatment takes the largest share. Ophthalmic corticosteroid formulations for uveitis and post-surgical inflammation, chemotherapy anti-emetic adjunct, and adrenal insufficiency replacement therapy also consume significant volumes globally.
The Q2 2026 average was USD 40.0/KG in the United States, USD 27.8/KG in China, USD 49.1/KG in Germany, and USD 38.1/KG in India. Germany remains the highest-priced market.
The global average rose from USD 32.00/KG in Q1 to about USD 34.56/KG in Q2, a gain of around 8.0%. Spring hospital formulary and emergency medicine procurement and firmer synthesis intermediate costs drove the H1 surge.
Hospital formulary and emergency medicine procurement cycles create alternating quarterly buying patterns. Post-procurement cycle moderation in Q1 and Q3 creates dips while spring and year-end hospital formulary and emergency medicine procurement surges in Q2 and Q4 drive upticks.
The global average is expected in the USD 34.80 to 38.50/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and hospital anti-inflammatory and emergency medicine sector demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on hospital and emergency demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to corticosteroid synthesis intermediate costs, hospital formulary procurement cycles, and emergency medicine stockpile replenishment. Steroid synthesis precursor prices and hospital formulary update schedules are key signals.
China and India hold the largest dexamethasone API synthesis capacity. Any corticosteroid synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time hospital formulary and emergency medicine formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor hospital formulary update schedules as primary demand signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.